CHU PHARMA exhibited at both CPHI Shanghai in the first half of the year and API China in the autumn, showcasing its three major business segments: generic drug APIs, innovative GLP-1 APIs, and customized injec···

The company participated in Pharmaceutical Africa for the second time, focusing on expanding into East Africa in addition to its traditional West African market. The company specifically promoted its GLP-1 weig···

The 90th API China Autumn Exhibition was held in Guangzhou. The company's core products were promoted as telpolide API and olfoglitazone tablet OEM, precisely targeting the formulation customization needs o···

The 86th API China Autumn Exhibition concluded successfully. CHU PHARMA showcased its full range of APIs and injectable drug manufacturing solutions. During the exhibition, it signed annual supply framework agr···

The 2020 Vietnam Ho Chi Minh City VIFA International Pharmaceutical Exhibition was successfully held, marking the company's first independent overseas participation in a professional pharmaceutical exhibiti···

Published: 2019-05-22 The 83rd API China (China International Pharmaceutical Ingredients Trade Fair) concluded successfully in Shanghai. This marked CHU PHARMA's first appearance at a major industry exhibit···